infect
bat
appar
jump
civet
raccoon
dog
human
broader
rang
transmiss
zoonot
potenti
anim
coronavirus
realiti
coronavirus
classifi
least
group
mammalian
virus
repres
group
felin
virus
resid
group
along
porcin
canin
rabbit
ferret
coronavirus
human
coronaviru
distinct
viru
associ
sever
acut
respiratori
syndrom
sar
within
group
virus
felin
porcin
canin
member
close
relat
distinct
serotyp
fcov
genet
relat
definit
distinguish
basi
specif
antibodi
wherea
serotyp
fcov
share
genet
porcin
viru
transmiss
gastroenter
viru
tgev
type
ii
fcov
share
homolog
canin
coronaviru
tgev
genom
sequenc
identifi
fcov
canin
coronaviru
sequenc
identifi
fcov
ii
indic
virus
like
origin
part
recombin
event
result
exchang
genom
region
recombin
common
event
coronavirus
fcov
isol
repeatedli
shown
commonli
infect
cat
worldwid
fcov
serotyp
ii
virus
howev
fcov
type
ii
virus
commonli
studi
greater
propens
replic
vitro
cell
cultur
unlik
type
fcov
similar
group
coronavirus
fcov
type
ii
virus
use
speciesspecif
aminopeptidas
n
cell
receptor
entri
consider
clinic
interest
manifest
fcov
biotyp
associ
distinct
diseas
patholog
felin
enter
coronaviru
fecv
biotyp
ubiquit
commonli
infect
gut
cat
gener
absenc
diseas
felin
infecti
periton
viru
fipv
biotyp
respons
fatal
system
diseas
fecv
fipv
catteri
nearli
ident
antigen
genet
geograph
separ
isol
display
greater
sequenc
differ
gener
accept
fipv
aris
fecv
strain
within
anim
import
understand
biotyp
relat
fcov
serotyp
fipv
fecv
repres
within
fcov
serotyp
ii
thu
term
biotyp
serotyp
distinct
confus
infecti
vehicl
transmiss
cat
cat
cell
cell
coronaviru
virion
viral
particl
fig
singlestrand
rna
genom
lie
within
core
virion
coat
nucleocapsid
protein
bilipid
membran
envelop
origin
host
cell
surround
nucleocapsid
coat
genom
embed
within
membran
envelop
major
protein
complet
repertoir
virion
particl
membran
protein
glycosyl
envelop
spike
protein
glycosyl
highli
hydrophob
membran
protein
smaller
hydrophob
envelop
protein
e
protein
cleav
part
result
transmembran
anchor
protein
cell
deriv
envelop
exterior
protein
hous
major
determin
viru
attach
thu
antibodi
neutral
serotyp
determin
order
gene
encod
fcov
genom
similar
coronavirus
inform
encod
polymeras
activ
requir
make
messeng
rna
genom
rna
locat
twothird
genom
fig
inform
encod
remain
third
genom
end
encod
protein
make
viral
particl
see
fig
gene
lie
order
e
n
addit
group
coronaviru
orf
encod
protein
unknown
function
lie
e
gene
downstream
n
gene
potenti
mutat
rna
genom
coronavirus
provid
background
variat
may
result
chang
natur
viral
antigen
diseas
result
viral
infect
wherea
antigen
chang
respons
vaccin
failur
case
avian
coronavirus
mutat
fcov
may
also
respons
metamorphosi
fairli
benign
enter
viru
highli
pathogen
rel
respons
fip
defin
question
schemat
gene
organ
fcov
genom
cap
structur
end
end
polyadenyl
tail
typic
structur
rna
use
messag
gener
protein
within
cell
entir
genom
approxim
nucleotid
base
length
overlap
orf
encod
protein
involv
rna
synthesi
requir
gener
mrna
genom
neg
sens
templat
spike
refer
gene
encod
highli
glycosyl
spike
protein
mem
refer
gene
encod
membran
protein
env
refer
gene
encod
envelop
protein
e
nucleocapsid
refer
gene
encod
nucleocapsid
protein
n
mutat
enter
viru
lead
pathogen
fatal
viral
progeni
larg
size
coronaviru
rna
genom
present
difficulti
identifi
singl
mutat
might
instrument
defin
virul
although
differ
also
identifi
within
extrem
larg
begin
genom
size
region
obstacl
pinpoint
mutat
potenti
involv
biotyp
determin
thu
gene
comparison
concentr
select
gene
lie
third
genom
intact
region
gene
associ
fecv
replic
gut
mutat
prevent
express
protein
identifi
fipv
strain
orf
gene
also
report
truncat
fecv
intact
fipv
strain
howev
delet
may
relev
biotyp
sinc
also
occur
vitro
passag
lin
colleagu
found
small
delet
could
found
biotyp
fcov
distribut
worldwid
ubiquit
virtual
cat
popul
great
variabl
preval
among
differ
cat
popul
tabl
viru
transmit
via
fecalor
rout
therefor
preval
fcov
infect
gener
associ
number
densiti
cat
hous
togeth
serolog
survey
davi
california
report
seropreval
pet
cat
live
privat
household
purebr
cat
live
catteri
among
relinquish
cat
british
shelter
risk
seroposit
higher
cat
origin
multicat
household
cat
singlecat
household
popul
cat
seroposit
certain
cat
could
remain
seroposit
year
longer
length
time
multicat
environ
also
increas
risk
exposur
estim
time
higher
cat
live
shelter
longer
day
although
environ
primari
sourc
fcov
mani
relinquish
cat
factor
intrins
shelter
environ
amplifi
shed
increas
spread
suscept
individu
one
studi
demonstr
fcovinfect
cat
enter
shelter
increas
fecv
shed
millionfold
week
hous
husbandri
practic
reduc
exposur
fece
contamin
environ
tremend
influenc
number
cat
expos
viru
shown
tabl
stray
feral
cat
gener
lower
preval
infect
pet
cat
like
due
lower
popul
densiti
buri
fece
outdoor
result
less
exposur
contamin
fecal
materi
compar
pet
cat
despit
fact
fcov
highli
contagi
wide
preval
multicat
environ
tabl
infect
cat
ever
develop
fip
syndrom
howev
depend
popul
densiti
length
stay
husbandri
practic
frequenc
rate
multicat
environ
low
fip
incid
everi
new
case
determin
base
cat
seen
veterinari
teach
hospit
unit
state
period
year
sever
risk
factor
develop
fip
identifi
sexual
intact
male
young
cat
highest
risk
develop
fip
cat
confirm
fip
seen
us
teach
hospit
month
year
age
one
studi
taiwan
fipconfirm
cat
less
year
old
risk
decreas
cat
reach
month
age
diseas
overrepres
certain
pure
breed
incid
fip
vari
greatli
region
countri
abyssinian
australian
mist
bengal
birman
british
shorthair
burmes
cornish
rex
himalayan
persian
ragdol
rex
breed
suggest
risk
factor
fip
develop
probabl
relat
bloodlin
within
breed
breed
demonstr
develop
fip
certain
lineag
occur
higher
frequenc
lineag
independ
environ
antibodi
titer
viral
shed
pattern
cat
high
fcov
titer
continu
exposur
persist
shedder
also
greater
risk
develop
fip
cat
immunosuppress
condit
advanc
felv
fiv
infect
suscept
develop
fip
expos
fcov
demonstr
fivinfect
cat
level
fecv
shed
increas
prolong
durat
fecal
shed
studi
demonstr
cat
fivinfect
group
later
develop
fip
theoriz
immunosuppress
chronic
fiv
infect
may
enhanc
evolut
select
fipv
mutant
increas
rate
fecv
replic
bowel
affect
individu
decreas
abil
fight
mutant
virus
may
occur
stress
also
play
larg
factor
whether
fcovinfect
cat
develop
fip
stressor
move
new
environ
cat
densiti
surgeri
may
increas
risk
individu
develop
fip
virtual
cat
shelter
multicat
environ
experi
level
stress
exposur
array
pathogen
thu
higher
incid
outbreak
expect
stress
environ
outbreak
defin
frequenc
fipconfirm
case
greater
multicat
environ
howev
rate
lower
may
character
outbreak
shelter
low
fip
preval
exampl
shelter
low
fip
frequenc
rate
higher
may
caus
concern
outbreak
preval
describ
sever
factor
associ
outbreak
includ
hostrel
factor
age
exposur
sex
lineag
suscept
virusrel
factor
strain
virul
high
replic
rate
intestin
tendenc
mutat
fipv
environmentrel
factor
frequenc
exposur
fecv
infect
dose
exposur
chronic
shedder
length
exposur
patholog
fip
classifi
form
noneffus
dri
effus
wet
form
although
gross
find
differ
microscop
lesion
similar
dri
wet
form
fip
furthermor
individu
patient
mixtur
form
identifi
wet
dri
form
fip
present
sever
system
diseas
produc
variabl
degre
thorac
abdomin
effus
effus
wet
form
produc
abund
clear
proteinac
strawcolor
periton
effus
fig
larg
amount
thick
exud
fluid
contain
copiou
amount
fibrin
see
fig
sever
distend
abdomen
howev
lesion
exud
accompani
perivascular
inflammatori
reaction
fig
distinct
characterist
fip
whitish
slightli
granular
inflammatori
exud
observ
kidney
omentum
cover
hepat
splenic
capsul
extend
parenchyma
fig
soft
thin
granular
whitish
layer
thin
plaqu
found
liver
splenic
capsul
fig
abdomin
organ
intestin
lymph
node
pancrea
urinari
bladder
may
affect
variabl
degre
inflammatori
exud
also
seen
lung
heart
frequent
affect
similar
small
slightli
granular
nodul
plaquelik
lesion
subtl
vascular
orient
noneffus
dri
form
fip
minim
effus
inflammatori
reaction
restrict
individu
organ
kidney
eye
brain
case
lesion
still
distinct
vascular
orient
characterist
diseas
inflammatori
respons
dri
form
character
perivascular
orient
granulomat
pyogranulomat
reaction
without
vascul
characterist
perivascular
granulomat
lesion
associ
fipv
infect
attribut
type
iii
iv
hypersensit
reaction
type
iii
hypersensit
occur
solubl
antigen
bind
antibodi
form
immun
complex
deposit
vessel
wall
also
lead
vascul
complement
activ
deposit
tissu
also
occur
fipv
respons
trigger
dissemin
intravascular
coagul
dic
vascul
blood
vessel
necrosi
type
iv
hypersensit
delay
reaction
due
excess
stimul
tcell
macrophag
may
also
contribut
granuloma
format
hand
patholog
find
associ
hypersensit
reaction
might
secondari
monocyt
activ
develop
vascul
support
new
find
releas
vascular
endotheli
growth
factor
vegf
fipvinfect
monocyt
induc
vascular
permeabl
effus
follow
exposur
fcov
primari
stage
infect
last
month
highest
level
viral
shed
occur
dramat
decreas
shed
year
report
natur
infect
cat
therefor
infect
cat
broadli
divid
categori
shed
fecv
rel
consist
long
period
time
consist
shedder
intermitt
shedder
nonshedd
one
studi
adult
shed
fecv
viru
time
appar
consist
shedder
persist
infect
strain
viru
cat
recov
infect
suscept
reinfect
strain
differ
strain
viru
demonstr
colon
major
site
fecv
persist
probabl
sourc
recurr
shed
presum
stress
factor
may
contribut
persist
intermitt
shed
especi
kitten
fecal
shed
start
within
week
remain
consist
high
level
month
infect
addit
kitten
shed
higher
level
fecv
adult
cat
one
studi
onethird
older
cat
kitten
juvenil
present
shelter
sacramento
california
usa
shed
fecv
time
entri
approxim
one
third
cat
posit
antibodi
specif
fcov
shed
viru
fece
particular
interest
cat
shed
viru
tend
higher
antibodi
titer
immunofluoresc
assay
ifa
titer
cat
longer
shed
viru
titer
quantif
viru
may
absolut
indic
viral
load
presenc
factor
inhibit
revers
trasncriptionpolymeras
chain
reaction
rtpcr
felin
fece
cat
may
abl
clear
infect
within
month
reinfect
viru
clearanc
correl
humor
cellmedi
immun
respons
viru
sever
studi
shown
fipv
replic
monocytesmacrophag
studi
regard
natur
innat
immun
respons
fipv
infect
natur
killer
cell
nk
typic
releas
type
interferon
respons
viral
infect
induc
interferonstimul
gene
isg
transcript
result
antivir
state
coronavirus
sarscov
shown
suppress
addit
monocyt
macrophag
releas
proinflammatori
cytokin
tumor
necrosi
factor
interleukin
il
respons
viral
pathogen
also
antiinflammatori
immun
regul
increas
turn
implic
mostli
cellmedi
adapt
immun
respons
cat
fip
shown
express
increas
level
cytokin
monocyt
macrophag
suspect
play
role
spleen
cat
capsular
surfac
show
sever
fibrin
inflammatori
reaction
extend
omentum
inflammatori
reaction
admix
copiou
amount
fibrin
viral
infect
humor
respons
result
gener
viral
neutral
antibodi
pertin
prevent
infect
howev
case
fipv
evid
humor
antibodi
respons
contribut
pathogenesi
mechan
call
antibodymedi
enhanc
antibodi
spike
protein
respons
viral
attach
facilit
uptak
viru
fc
receptor
macrophag
macrophag
fipvinfect
cat
releas
increas
level
bcell
differenti
surviv
cytokin
suggest
enhanc
bcell
activ
play
role
antibodymedi
enhanc
infect
vaccin
develop
discourag
mainli
concern
regard
vaccineinduc
enhanc
infect
howev
antibodymedi
enhanc
fcov
infect
experiment
demonstr
laboratori
strain
field
strain
addit
clearanc
fcov
infect
natur
infect
cat
associ
presenc
antibodi
spike
protein
fipv
overal
conclus
experiment
infect
cat
indic
humor
immun
play
larg
role
prevent
fipv
infect
spread
might
rather
contribut
pathogenesi
least
laboratori
set
contrast
humor
immun
appear
cellmedi
immun
respons
play
import
role
fight
fipv
infect
sever
studi
support
assumpt
pedersen
colleagu
hypothes
differ
humor
cellular
immun
manifest
differ
pathogenesi
cat
fip
suggest
strong
humor
respons
weak
cellular
immun
lead
wet
effus
form
fip
humor
immun
intermedi
cellular
immun
respons
result
dri
form
fip
shown
coronaviru
infect
strong
cellular
respons
prevent
diseas
addit
infect
felv
felin
leukemia
viru
strong
suppressor
cellular
immun
associ
higher
incid
fip
fip
character
deplet
tlymphocyt
tlymphocyt
count
remain
low
clear
deplet
occur
cell
appear
suscept
fipv
infect
de
grootmijn
theoriz
deplet
lead
acut
immunodefici
virusinduc
tcell
respons
face
uphil
battl
fight
infect
recent
interferon
shown
play
signific
role
immun
pathogenesi
associ
fipv
infect
tcell
bcell
nk
cell
profession
antigenpres
cell
apc
macrophag
dendrit
cell
secret
import
activ
immun
cell
especi
macrophag
like
import
earli
host
defens
macrophag
recognit
pamp
pathogenassoci
molecular
pattern
induc
releas
chemokin
attract
nk
cell
site
inflamm
promot
synthesi
neg
regul
product
includ
antiinflammatori
cytokin
well
glucocorticoid
therefor
crucial
earli
innat
respons
well
link
innat
adapt
immun
respons
especi
cellmedi
adapt
immun
interestingli
clinic
normal
fcovinfect
cat
live
catteri
higher
serum
level
cat
fulmin
fipv
infect
suggest
import
role
suppress
develop
fip
respons
compromis
sever
factor
fipvinfect
cat
includ
stress
elev
releas
link
apoptosi
tlymphocyt
well
macrophag
upregul
aminopeptidas
n
receptor
apn
receptor
fipv
type
ii
signific
chang
observ
cat
immun
fipv
subsequ
challeng
regard
proinflammatori
cytokin
messeng
rna
mrna
level
blood
leukocyt
specif
cat
develop
diseas
express
high
level
low
level
contrast
cat
immun
develop
fip
level
low
level
elev
summari
studi
suggest
fipv
infect
lead
reduc
cellmedi
immun
possibl
compromis
releas
blood
leukocyt
increas
releas
infect
monocytesmacrophag
subsequ
tcell
deplet
shelter
cat
live
environ
predispos
increas
chronic
stress
stress
lead
elev
glucocorticoid
releas
turn
neg
regul
product
impair
tcell
function
neg
effect
cellmedi
immun
consid
cellmedi
immun
like
respons
clearanc
fipv
infect
becom
obviou
reduc
stress
shelter
cat
potenti
improv
odd
success
combat
infect
addit
close
contact
cat
shelter
facilit
transmiss
viru
enabl
rna
viru
fcov
prolifer
evolv
eventu
virul
viru
address
problem
widespread
fecv
infect
shelter
cat
well
increas
risk
fipv
infect
consequ
diseas
critic
increas
effort
elucid
role
host
immun
respons
fcov
cat
initi
expos
fcov
may
asymptomat
diarrhea
andor
upper
respiratori
sign
cat
coronavirusassoci
enter
mild
sign
vomit
andor
diarrhea
short
durat
last
week
even
month
gastrointestin
sign
gener
mild
subclin
therapi
requir
case
although
often
distinct
made
wet
dri
form
fip
mutual
exclus
progress
diseas
may
chang
one
form
form
array
multipl
clinic
sign
mani
present
none
pathognomon
diseas
patient
may
asymptomat
present
differ
level
depress
anorexia
common
find
includ
weight
loss
pale
mucou
membran
fever
unknown
origin
uveiti
wet
effus
form
see
video
onlin
within
articl
www
vetsmalltheclinicscom
novemb
issu
ascit
abdomin
distent
common
present
fig
fluid
wave
physic
examin
may
evid
cat
less
fluid
accumul
detect
abdomin
ultrasound
pleural
effus
secondari
dyspnea
tachypnea
muffl
heart
sound
may
present
fig
wherea
pericardi
effus
uncommon
wet
form
also
associ
sever
clinic
sign
identifi
dri
form
describ
later
common
sign
dri
noneffus
form
mild
intermitt
fever
decreas
appetit
weight
loss
stunt
growth
depress
pale
yellow
mucou
membran
palpabl
abdomin
organ
enlarg
pyogranulomat
lesion
develop
one
abdomin
organ
clinic
sign
associ
affect
organ
mimick
hepat
kidney
insuffici
intestin
tumor
pyogranulomat
lesion
detect
abdomin
palpat
enlarg
mesenter
lymph
node
palpabl
nodular
irregular
surfac
kidney
liver
granuloma
form
intestin
constip
diarrhea
andor
vomit
may
major
clinic
sign
observ
uveiti
common
ocular
abnorm
document
fip
case
ocular
lesion
may
present
iriti
cuf
retin
vasculatur
kerat
precipit
cornea
fig
neurolog
sign
also
seen
fip
common
abnorm
mental
statu
ataxia
central
vestibular
sign
hyperesthesia
nystagmu
seizur
demonstr
part
central
nervou
system
becom
affect
diseas
almost
half
centuri
pass
sinc
first
descript
fip
cat
nonetheless
diagnosi
syndrom
remain
one
greatest
challeng
veterinarian
despit
great
advanc
laboratori
diagnost
techniqu
past
decad
diagnosi
fip
still
base
combin
histori
risk
factor
signal
clinic
abnorm
laboratori
find
except
histopatholog
immunostain
singl
laboratori
test
definit
diagnos
fip
syndrom
likewis
diagnost
procedur
identifi
fcovinfect
cat
go
develop
fip
diagnost
process
start
good
histori
comprehens
physic
examin
complet
blood
cell
count
cbc
biochem
profil
help
expand
clinic
pictur
fip
often
chronic
ill
felin
patient
nonregen
anemia
may
present
abnorm
may
includ
limit
lymphopenia
neutrophilia
thrombocytopenia
hyperbilirubinemia
elev
aspart
aminotransferas
ast
hyperproteinemia
mgdl
consist
find
present
approxim
cat
fip
mainli
elev
serum
globulin
level
caus
specif
antibodi
respons
presenc
complement
immun
complex
bloodstream
hypoalbuminemia
present
associ
hepat
insuffici
increas
loss
endotheli
leakag
result
decreas
albumin
globulin
g
ratio
tabl
low
g
ratio
strongli
associ
fip
caus
hyperglobulinemia
alway
rule
acutephas
protein
class
protein
whose
plasma
concentr
increas
decreas
respons
inflammatori
disord
acid
glycoprotein
level
greater
gl
plasma
effus
suggest
fip
diagnost
accuraci
provid
tabl
howev
risk
factor
clinic
sign
taken
account
appropri
interpret
sinc
inflammatori
condit
also
caus
increas
protein
therefor
cat
clinic
sign
support
risk
factor
acid
glycoprotein
valu
gl
consist
fip
wherea
asymptomat
cat
acid
glycoprotein
valu
equal
gl
need
support
diagnosi
fip
cat
wet
form
fip
effus
abdomen
pleural
space
typic
clear
strawcolor
viscou
due
high
protein
content
see
video
onlin
within
articl
wwwvetsmalltheclinicscom
novemb
issu
sometim
effus
red
pink
almost
colorless
even
chylu
character
nonsept
modifi
transud
pyogranulomat
exud
cytolog
gener
document
low
cell
count
nucleat
cellsml
consist
neutrophil
macrophag
high
protein
content
gdl
high
g
ratio
effus
unlik
seen
fip
syndrom
wherea
g
ratio
less
highli
suggest
effus
fip
rivalta
test
origin
design
one
centuri
ago
differenti
transud
exud
provid
good
predict
valu
compar
expens
techniqu
tabl
detail
descript
perform
test
provid
written
video
resourc
elsewher
due
simplic
low
cost
rivalta
test
perform
case
effus
cat
ifa
use
detect
macrophag
infect
fcov
effus
posit
stain
macrophag
predict
fip
falseneg
result
occur
low
level
infect
multicat
environ
quantif
fcov
antibodi
valuabl
follow
identifi
cat
expos
fcov
prior
introduct
fcovfre
catteri
screen
catteri
infect
test
cat
contact
suspect
fcov
shedder
establish
breed
program
base
fcov
statu
classifi
cat
base
shed
level
purpos
isol
fcoverad
program
although
sever
assay
current
avail
detect
antibodi
fcov
serolog
test
capabl
diagnos
fip
syndrom
serolog
use
differenti
fecv
fipv
infect
posit
titer
indic
given
cat
expos
fcov
predict
cat
ever
develop
fip
convers
neg
titer
good
predictor
absenc
infect
neg
predict
valu
diseas
caus
fipv
aris
mutant
common
fecv
control
prevent
fip
syndrom
must
direct
first
control
parent
viru
therefor
knowledg
antibodi
titer
fcov
help
control
erad
viru
multicat
environ
approxim
one
third
cat
present
antibodi
fcov
shed
fecv
fece
cat
titer
less
often
shed
low
level
fecv
cat
frequent
stop
shed
isol
cat
cat
titer
greater
frequent
shed
high
level
fecv
isol
cat
stop
shed
concurr
decreas
titer
cat
persist
high
antibodi
titer
gener
consist
shed
isol
stress
reduct
promot
decreas
shed
remov
consist
shedder
multicat
environ
taken
consider
suggest
high
antibodi
titer
good
predictor
develop
fip
posit
predict
valu
tabl
howev
sever
studi
describ
cat
confirm
fip
serolog
respons
fcov
detect
particularli
true
cat
wet
form
fip
suggest
larg
amount
viru
present
bind
antibodi
make
unavail
antibodi
test
case
altern
explan
antibodi
fcov
lost
effus
protein
transloc
due
vascul
quantif
antibodi
effus
correl
presenc
antibodi
blood
suggest
effus
may
use
test
sera
howev
studi
shown
correl
magnitud
antibodi
titer
occurr
fip
specif
antibodi
fcov
may
also
detect
csf
cat
neurolog
form
fip
diagnost
valu
presenc
limit
antifcov
antibodi
also
detect
cat
brain
tumor
addit
vaccin
also
result
posit
titer
differenti
natur
exposur
express
gene
report
associ
fipv
infect
consequ
cat
clinic
sign
fip
would
titer
protein
higher
cat
infect
fecv
unfortun
studi
suggest
find
may
artifactu
relat
specif
isol
test
furthermor
intact
gene
describ
field
strain
fecv
test
antibodi
direct
protein
compar
ifa
one
studi
author
show
protein
assay
high
sensit
poor
specif
mani
falseposit
result
occur
uninfect
anim
therefor
test
use
alon
diagnosi
fip
regardless
find
protein
test
advertis
fip
specif
elisa
commerci
laboratori
unit
state
sever
protocol
includ
enzymelink
immunosorb
assay
elisa
kineticsbas
elisa
viru
neutral
assay
indirect
ifa
develop
detect
antibodi
specif
fcov
choic
laboratori
import
sinc
methodolog
antibodi
titer
result
vari
significantli
among
laboratori
clinician
encourag
select
diagnost
servic
methodolog
use
support
peerreview
public
addit
result
provid
endpoint
titer
one
also
understand
falseposit
result
occur
exampl
due
antinuclear
antibodi
ana
caus
concurr
infect
fiv
ehrlichia
cani
autoimmun
diseas
recent
vaccin
certain
drug
includ
thiamazol
methimazol
rtpcr
assay
detect
fcov
varieti
sampl
fece
blood
effus
cerebrospin
fluid
tissu
saliva
high
sensit
tabl
multicat
environ
rtpcr
valuabl
tool
identifi
continu
shedder
part
fcov
manag
plan
howev
repeat
fecal
rtpcr
test
gener
necessari
accur
document
cat
shed
fcov
order
demonstr
cat
stop
shed
viru
least
consecut
monthli
neg
fecal
test
obtain
cat
becom
seroneg
ifa
due
inherit
risk
falseneg
falseposit
result
rtpcr
result
best
interpret
conjunct
serolog
result
rtpcr
discrimin
fecv
fipv
due
variou
singl
nucleotid
polymorph
snp
delet
mutat
present
biotyp
sometim
even
identifi
cat
time
write
specif
genet
determin
trigger
evolut
fecv
fipv
otherwis
distinguish
biotyp
confirm
due
particular
fcov
specif
rtpcr
fipv
yet
design
despit
fecv
tropism
felin
enterocyt
enter
viru
detect
rtpcr
bloodstream
healthi
cat
therefor
detect
fcov
blood
indic
presenc
fipv
sole
support
diagnosi
fip
syndrom
addit
presenc
viremia
appear
predispos
cat
develop
fip
presenc
fcov
effus
detect
rtpcr
associ
fip
syndrom
report
falseposit
result
indic
specif
limit
combin
data
three
initi
studi
indic
sensit
specif
diagnosi
fip
use
rtpcr
detect
fcov
rna
effus
fipconfirm
cat
cat
effus
due
caus
tabl
detect
fcov
rtpcr
biopsi
sampl
fine
needl
aspir
affect
organ
consid
suggest
system
diseas
blood
contamin
sampl
rule
howev
suggest
histopatholog
examin
immunohistochemistri
perform
confirm
diagnosi
sinc
one
studi
cat
without
clinic
sign
fip
posit
fcov
tissu
sampl
rtpcr
pcr
procedur
target
mrna
highli
conserv
gene
fcov
describ
potenti
detect
replic
viru
concept
base
assumpt
pathogenesi
fipv
mutant
viru
replic
peripher
blood
monocyt
tissu
macrophag
therefor
detect
fcov
mrna
blood
sampl
would
correl
replic
fipv
develop
fip
two
studi
europ
one
malaysia
use
techniqu
sensit
rang
howev
percentag
fals
neg
vari
variat
may
associ
popul
select
criteria
use
diagnosi
fip
differ
rna
extract
procedur
may
affect
qualiti
rna
templat
downstream
assay
colleg
veterinari
medicin
auburn
provid
pcr
test
blood
effus
tissu
result
provid
semiquantit
scale
unfortun
time
write
epidemiolog
data
unit
state
avail
use
mrna
rtpcr
assay
longitudin
studi
need
determin
cat
replic
fcov
bloodstream
higher
risk
develop
fip
futur
gold
standard
definit
diagnost
test
avail
fip
provid
histopatholog
examin
major
case
fip
diagnos
gross
histopatholog
lesion
alon
distinct
inflammatori
infiltr
character
vari
degre
sever
present
combin
macrophag
lymphocyt
plasma
cell
mix
lesser
number
neutrophil
hallmark
lesion
perivascular
granulomat
pyogranulomat
inflamm
vascul
vessel
primarili
affect
small
mediums
vein
fig
perivascular
macrophagedomin
infiltr
occasion
extend
vessel
wall
produc
focal
area
necrosi
sporad
smooth
muscl
hyperplasia
fig
vascul
one
microscop
lesion
distinguish
diseas
inflammatori
infecti
diseas
case
noneffus
dri
form
brain
spinal
cord
eye
might
site
affect
histopatholog
lesion
brain
could
includ
periventricul
ventricul
ependym
andor
leptomening
vascularori
inflammatori
reaction
without
vascul
distinct
inflammatori
lesion
fig
lesion
affect
eye
report
bilater
granulomat
anterior
uveiti
often
accompani
chorioretin
recent
nonprurit
intraderm
cutan
form
fip
describ
skin
lesion
describ
slightli
rais
intraderm
papul
dorsal
neck
later
thorac
wall
one
case
report
patient
also
infect
fiv
pathognomon
lesion
present
histopatholog
detect
intracellular
fcov
antigen
macrophag
effus
immunofluoresc
tissu
immunohistochemistri
altern
diagnost
procedur
fig
unfortun
procedur
differenti
fipv
fecv
posit
antigen
stain
macrophag
effus
granulomat
lesion
confirm
diagnosi
fip
instanc
lesion
resembl
system
fungal
infect
may
pertin
rule
special
histochem
stain
immunostain
effus
falseneg
result
may
occur
explain
possibl
insuffici
number
macrophag
effus
smear
presenc
high
quantiti
host
antifcov
antibodi
effus
compet
assay
develop
fip
prognosi
poor
grave
report
surviv
time
day
anim
eventu
die
diseas
euthanasia
recommend
qualiti
life
becom
poor
although
treatment
focus
reduc
inflammatori
hyperimmun
respons
studi
publish
prove
benefici
effect
corticosteroid
sever
antivir
immunosuppress
consid
use
fip
case
review
evidencebas
data
therapi
provid
elsewher
antivir
ribavirin
vidarabin
effect
inhibit
viru
cell
cultur
toxic
cat
human
contraind
oral
ineffect
subcutan
administr
current
felin
interferon
treatment
one
option
treat
fipvinfect
cat
although
studi
show
differ
efficaci
immunosuppress
prednisonedexamethason
immunosuppress
dose
treatment
choic
treatment
cur
may
slow
progress
diseas
recent
new
immunostimul
name
polyprenyl
improv
surviv
cat
dri
form
fip
still
aliv
year
diagnosi
polyprenyl
enhanc
cellmed
immun
upregul
biosynthesi
mrna
cytokin
believ
requir
elimin
fip
viru
studi
larger
number
cat
current
way
modifiedl
nonadjuv
intranas
coronaviru
vaccin
avail
may
provid
protect
cat
previous
expos
fcov
prevent
fraction
report
vaccin
could
advantag
cat
neg
fcov
titer
enter
multicat
environ
known
endem
fcov
expos
fcov
howev
effect
question
situat
cat
alreadi
expos
frequent
occur
multicat
environ
vaccin
current
recommend
core
vaccin
felin
patient
sinc
immunocompromis
cat
shed
much
virus
perhap
less
abil
fight
mutant
strain
screen
control
infecti
organ
felv
fiv
multicat
environ
recommend
manag
fip
current
practic
shelter
keep
felvand
fivinfect
individu
special
need
adopt
import
shelter
manag
staff
understand
addit
risk
popul
pose
rest
felin
resid
ensur
measur
taken
minim
risk
one
might
reconsid
maintain
popul
shelter
environ
better
option
may
hous
felvandor
fivposit
cat
appropri
rescu
organ
separ
rest
shelter
popul
depopul
felvandor
fivposit
cat
also
altern
nois
overcrowd
ineffici
ventil
mani
stress
factor
especi
shelter
catteri
environ
may
contribut
develop
fip
given
popul
design
manag
facil
hous
cat
issu
address
establish
consist
introduc
new
approach
infect
control
measur
throughout
facil
access
polici
procedur
may
prove
help
keep
complianc
among
staff
institut
maintain
appropri
protocol
fcov
surviv
week
dri
environ
transmit
via
fece
fomit
proper
clean
disinfect
essenti
manag
infect
felin
popul
major
organ
debri
remov
prior
use
disinfect
simpl
dilut
sodium
hypochlorit
equival
dilut
commerci
avail
bleach
option
protect
light
prepar
time
use
major
disinfect
effect
inactiv
fcov
howev
suggest
disinfect
may
appropri
oxid
agent
eg
trifect
virkon
oxysept
consid
effect
wherea
quaternari
ammonium
compound
eg
roccal
parvosol
diquat
biguanid
chlorhexidin
phenol
compound
eg
lysol
tektrol
amphyl
limit
activ
envelop
virus
viru
rare
found
saliva
healthi
cat
contact
feed
bowl
probabl
play
minor
role
transmiss
compar
share
litter
box
among
individu
nonetheless
proper
disinfect
potenti
contamin
surfac
warrant
singl
cat
diagnos
fip
recommend
wait
least
month
new
cat
introduc
household
fcov
infect
like
minim
absent
environ
fip
diagnos
multicat
household
need
isol
cat
like
alreadi
expos
fecv
cat
environ
genet
relat
risk
fip
occur
may
higher
due
lineag
predisposit
key
control
fcov
shelterfost
home
minim
viral
load
environ
reduc
number
cat
per
roomcag
group
high
fcov
shedder
low
shedder
neg
cat
separ
decreas
stress
control
concurr
ill
keep
surfac
litter
tray
clean
provid
suffici
litter
tray
best
method
achiev
goal
tabl
despit
precaut
evalu
infect
statu
popul
still
warrant
success
control
fcov
multicat
environ
catteri
sever
method
attempt
minim
fip
outbreak
kitten
remov
catteri
mother
posit
titer
fcov
isol
week
age
prevent
exposur
fcov
method
may
prove
effect
kitten
protect
fcov
via
matern
antibodi
week
age
although
genet
compon
predisposit
well
establish
remov
cat
produc
litter
affect
diseas
breed
program
recommend
viru
easili
transmit
via
fomit
isol
particularli
effect
method
control
depopul
shedder
gener
effect
requir
specif
diagnost
test
identifi
shedder
may
cost
effect
catteri
shelter
current
complet
elimin
fcov
multicat
environ
would
seem
virtual
imposs
outbreak
fip
occur
shelter
set
sever
option
consid
increas
sanit
isol
segreg
infect
uninfect
anim
depopul
adopterscommun
educ
characterist
common
method
prevent
control
fip
outbreak
multicat
environ
present
tabl
even
shelter
follow
strict
sanit
biosecur
guidelin
period
review
updat
clean
practic
especi
event
outbreak
recommend
good
protocol
reduc
stress
amount
fomit
transmiss
fcov
keep
cat
cage
clean
daili
incag
spot
clean
deep
clean
cage
individu
resid
chang
detail
approach
fip
outbreak
shelter
foster
home
publish
elsewher
isol
ineffici
outbreak
occur
incom
kitten
greatest
risk
physic
separ
exposedatrisk
cat
newli
acquir
one
recommend
separ
creat
physic
barrier
also
involv
client
staff
flow
within
facil
handl
new
popul
first
expos
cat
last
procedur
may
elimin
infect
fcov
least
reduc
exposur
viru
depopul
may
use
control
fip
outbreak
requir
remov
expos
popul
comprehens
disinfect
facil
equip
adopt
strict
biosecur
method
unfeas
shelter
depopul
cat
seroreact
fcov
recommend
sinc
cat
antibodi
viru
ever
develop
fip
addit
depopul
pose
ethic
well
public
relat
issu
shelter
although
incid
fip
fairli
low
outbreak
occur
impact
facil
profoundli
damag
cat
adopt
shelter
develop
fip
caus
emot
financi
traumat
experi
adopt
damag
reput
shelter
ultim
case
result
lower
adopt
higher
euthanasia
rate
facil
educ
adopt
fcov
fip
unfortun
consequ
infect
multicat
facil
prior
adopt
cat
crucial
maintain
good
relationship
public
inform
regard
sign
symptom
help
make
quicker
diagnosi
patientcli
unfortun
scenario
aris
interdisciplinari
approach
need
better
understand
relationship
fcov
fip
epizoolog
diagnost
assist
provid
state
manag
protocol
aim
decreas
risk
cat
shelter
develop
fip
although
fip
undeni
link
fcov
infect
mechan
permit
rather
benign
fecv
evolv
fipv
still
unknown
fip
intim
connect
immun
respons
affect
anim
detail
interact
pathogenesi
fipv
valuabl
design
therapeut
prophylact
prevent
understand
prophylact
immun
current
best
weapon
diminish
occurr
fip
multicat
environ
use
appropri
biosecur
protocol
unfortun
highli
infecti
natur
fecv
lack
understand
evolut
fipv
caus
either
dri
wet
form
fip
make
elimin
risk
virtual
imposs
